Anita Lim

Anita completed a BSc in pharmacology at the University of Auckland (New Zealand) in 1998. She went on to complete her MSc (Grade ‘A’ with First Class Honours) at the same university which was awarded in 2001 for a thesis on the role of oral tramadol in postoperative pain management. Anita then moved to London where she worked as a researcher on acute and chronic pain studies at the department of anaesthetics at Queen Mary University. In 2002, she moved to industry where she worked as a senior clinical research scientist for GlaxoSmithKline (Clinical Pharmacology and Discovery Medicine, Psychiatry). Anita returned to academia in 2004 and worked as a clinical trial manager for paediatric oncology at Queen Mary University. Between 2005 and 2009 she completed a PhD in cancer epidemiology with Professor Peter Sasieni at Queen Mary University (Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine). Her PhD thesis investigated the potential for achieving earlier diagnosis of ovarian cancer via symptoms-based testing. After her PhD, Anita led a nationwide project which examined the history of presentation and delays in diagnosis of young women with cervical cancer (Kings College London, 2010-2012). From 2012-2017 she worked at the Centre for Cancer Prevention at Queen Mary University as a senior epidemiologist in cervical cancer screening and prevention. In 2018 she returned to Kings College London. Here, her work is focused mainly on HPV self-sampling for cervical screening non-attenders, novel approaches to cervical screening and early diagnosis of cancer in GP primary care.